AbbVie CMO: Your Expert Partner In Bringing Biologics To Market

Source: AbbVie

By John Casey, Director, Biologics Contract Manufacturing, Jon Best, Director, Business Development


The process of developing and manufacturing a monoclonal antibody (mAb) therapeutic can be overwhelming. With numerous variables impacting product quality, many organizations developing these complex molecules require proven expertise and support to timely deliver a safe, reliable therapeutic that meets patient needs.

By choosing AbbVie, you’re partnering with a highly experienced and trusted organization that has brought many Biologics to market. Much more than a CMO, AbbVie is an established biopharmaceutical partner to provide comprehensive support at every phase of your mAb’s development to commercial life cycle.

With a long-standing track record in biopharmaceutical process development, a knowledgeable scientific team, world-class global facilities, and exceptional end-to-end Biologics capabilities, AbbVie has a comprehensive platform to support the development, manufacture and commercialization of your Biologics therapeutic. Robust quality systems are in place to assure consistent, high quality supply, providing you with confidence in milestone achievement. Moreover, our total commitment to treating your program as if it were our own ensures strong collaboration and ultimate success all the way from innovation to commercialization.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma